| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8686301 | Neurobiology of Disease | 2018 | 28 Pages |
Abstract
EZH1 is dysregulated in schizophrenia, sensitive to antipsychotic medications, and a brain-enriched miR-132 target that controls neurobehavioral phenotypes.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Andrea L. Johnstone, Jiaqi J. O'Reilly, Annika J. Patel, Zhihong Guo, Nadja S. Andrade, Marco Magistri, Lubov Nathanson, Rustam Esanov, Brooke H. Miller, Gustavo Turecki, Shaun P. Brothers, Zane Zeier, Claes Wahlestedt,